Kurt Karst is speaking at a webinar for FDANEWS

FDANEWS Webinar – Kurt Karst is speaking a on “Cut Drug Approval Time:

Is A 505(b)(2) the Right Way to Go”

March 25 – 1:30 to 3 pm EST